Associations of plasma omega-6 and omega-3 fatty acids with overall and 19 site-specific cancers: A population-based cohort study in UK Biobank
- PMID: 39417685
- DOI: 10.1002/ijc.35226
Associations of plasma omega-6 and omega-3 fatty acids with overall and 19 site-specific cancers: A population-based cohort study in UK Biobank
Abstract
Previous epidemiological studies on the associations between polyunsaturated fatty acids (PUFAs) and cancer incidence have been inconsistent. We investigated the associations of plasma omega-3 and omega-6 PUFAs with the incidence of overall and 19 site-specific cancers in a large prospective cohort. 253,138 eligible UK Biobank participants were included in our study. With a mean follow-up of 12.9 years, 29,838 participants were diagnosed with cancer. The plasma levels of omega-3 and omega-6 PUFAs were expressed as percentages of total fatty acids (omega-3% and omega-6%). In our main models, both omega-6% and omega-3% were inversely associated with overall cancer incidence (HR per SD = 0.98, 95% CI = 0.96-0.99; HR per SD = 0.99, 95% CI = 0.97-1.00; respectively). Of the 19 site-specific cancers available, 14 were associated with omega-6% and five with omega-3%, all indicating inverse associations, with the exception that prostate cancer was positively associated with omega-3% (HR per SD = 1.03, 95% CI = 1.01-1.05). Our population-based cohort study in UK Biobank indicates small inverse associations of plasma omega-6 and omega-3 PUFAs with the incidence of overall and most site-specific cancers, although there are notable exceptions, such as prostate cancer.
Keywords: cancer incidence; omega‐3 fatty acids; omega‐6 fatty acids; polyunsaturated fatty acids; prospective cohort study.
© 2024 The Author(s). International Journal of Cancer published by John Wiley & Sons Ltd on behalf of UICC.
Update of
-
Associations of plasma omega-6 and omega-3 fatty acids with overall and 19 site-specific cancers: a population-based cohort study in UK Biobank.medRxiv [Preprint]. 2024 Jan 22:2024.01.21.24301568. doi: 10.1101/2024.01.21.24301568. medRxiv. 2024. Update in: Int J Cancer. 2024 Oct 17. doi: 10.1002/ijc.35226 PMID: 38343844 Free PMC article. Updated. Preprint.
Similar articles
-
Associations of plasma omega-6 and omega-3 fatty acids with overall and 19 site-specific cancers: a population-based cohort study in UK Biobank.medRxiv [Preprint]. 2024 Jan 22:2024.01.21.24301568. doi: 10.1101/2024.01.21.24301568. medRxiv. 2024. Update in: Int J Cancer. 2024 Oct 17. doi: 10.1002/ijc.35226 PMID: 38343844 Free PMC article. Updated. Preprint.
-
Higher ratio of plasma omega-6/omega-3 fatty acids is associated with greater risk of all-cause, cancer, and cardiovascular mortality: A population-based cohort study in UK Biobank.Elife. 2024 Apr 5;12:RP90132. doi: 10.7554/eLife.90132. Elife. 2024. PMID: 38578269 Free PMC article.
-
Higher ratio of plasma omega-6/omega-3 fatty acids is associated with greater risk of all-cause, cancer, and cardiovascular mortality: a population-based cohort study in UK Biobank.medRxiv [Preprint]. 2024 Jan 10:2023.01.16.23284631. doi: 10.1101/2023.01.16.23284631. medRxiv. 2024. Update in: Elife. 2024 Apr 05;12:RP90132. doi: 10.7554/eLife.90132 PMID: 36711941 Free PMC article. Updated. Preprint.
-
Dietary fatty acids and risk for Alzheimer's disease, dementia, and mild cognitive impairment: A prospective cohort meta-analysis.Nutrition. 2021 Oct;90:111355. doi: 10.1016/j.nut.2021.111355. Epub 2021 May 26. Nutrition. 2021. PMID: 34218119 Review.
-
Omega-3 fatty acids for the treatment of dementia.Cochrane Database Syst Rev. 2016 Apr 11;4(4):CD009002. doi: 10.1002/14651858.CD009002.pub3. Cochrane Database Syst Rev. 2016. PMID: 27063583 Free PMC article. Review.
References
REFERENCES
-
- Vos T, Lim SS, Abbafati C, et al. Global burden of 369 diseases and injuries in 204 countries and territories, 1990–2019: a systematic analysis for the Global Burden of Disease Study 2019. Lancet. 2020;396(10258):1204‐1222.
-
- Hanson S, Thorpe G, Winstanley L, et al. Omega‐3, omega‐6 and total dietary polyunsaturated fat on cancer incidence: systematic review and meta‐analysis of randomised trials. Br J Cancer. 2020;122(8):1260‐1270.
-
- Lee KH, Seong HJ, Kim G, et al. Consumption of fish and ω‐3 fatty acids and cancer risk: an umbrella review of meta‐analyses of observational studies. Adv Nutr. 2020;11(5):1134‐1149.
-
- Shahidi F, Ambigaipalan P. Omega‐3 polyunsaturated fatty acids and their health benefits. Annu Rev Food Sci Technol. 2018;9:345‐381.
-
- Gleissman H, Johnsen JI, Kogner P. Omega‐3 fatty acids in cancer, the protectors of good and the killers of evil? Exp Cell Res. 2010;316(8):1365‐1373.
Grants and funding
LinkOut - more resources
Full Text Sources
